Want to see IN:TTKHLTCARE full AI Analyst Report?
Top Page
TTK Healthcare Limited
(TTKHLTCARE)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹1,291.00
▲(19.24% Upside)
Action:Reiterated
Date:09/09/26
The score is anchored by mixed financial performance: a very strong, low-leverage balance sheet is outweighed by sustained negative operating/free cash flow and recent margin pressure. Technicals are a clear positive with the stock in a strong uptrend, while valuation is only neutral-to-slightly weak given a mid-to-high P/E and low dividend yield.
Positive Factors
Very low leverage
The highly conservative capital structure reduces solvency risk and preserves financial flexibility. Low debt should leave more capacity to absorb operating volatility, support product investment, and fund expansion without substantial interest or refinancing pressure.
Negative Factors
Sustained negative cash generation
Persistent cash burn weakens the conversion of reported earnings into usable funds and can constrain internally financed growth. Although free cash flow improved versus the prior year, a sustained return to positive operating cash generation remains important for financial flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage
The highly conservative capital structure reduces solvency risk and preserves financial flexibility. Low debt should leave more capacity to absorb operating volatility, support product investment, and fund expansion without substantial interest or refinancing pressure.
Read all positive factors
TTK Healthcare Limited (TTKHLTCARE) vs. iShares MSCI India ETF (INDA)
Market Cap
₹15.77B
Dividend Yield0.89%
Average Volume (3M)2.97K
Price to Earnings (P/E)21.3
Beta (1Y)0.84
Revenue Growth8.34%
EPS Growth17.25%
CountryIN
Employees1,478
SectorGeneral
Sector StrengthN/A
IndustryDrug Manufacturers - General
Share Statistics
EPS (TTM)52.34
Shares Outstanding14,130,333
10 Day Avg. Volume4,795
30 Day Avg. Volume2,972
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)0.99
Price to Sales (P/S)1.29
P/FCF Ratio-41.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TTK Healthcare Limited Business Overview & Revenue Model
Company Description
TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceutical...
How the Company Makes Money
TTK Healthcare primarily makes money by selling healthcare products and medical devices under its own brands and through institutional supply. Its revenue model is driven by: (1) Consumer healthcare sales: Revenue from branded consumer/OTC healthc...
TTK Healthcare Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
86
Very Positive
Cash Flow
28
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.88B | 8.57B | 8.73B | 7.48B | 7.25B | 5.99B |
| Gross Profit | 3.37B | 2.80B | 5.04B | 4.07B | 3.77B | 3.09B |
| EBITDA | 883.75M | 261.76M | 1.06B | 999.35M | 796.81M | 406.58M |
| Net Income | 739.60M | 656.80M | 816.57M | 628.42M | 6.40B | 415.88M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 13.29B | 12.81B | 12.01B | 11.70B | 5.59B |
| Cash, Cash Equivalents and Short-Term Investments | 9.36B | 9.75B | 8.55B | 8.45B | 8.47B | 2.73B |
| Total Debt | 0.00 | 243.78M | 242.19M | 228.11M | 273.29M | 222.13M |
| Total Liabilities | -11.15B | 2.14B | 2.16B | 2.00B | 2.17B | 2.29B |
| Stockholders Equity | 11.15B | 11.15B | 10.65B | 10.01B | 9.53B | 3.30B |
Cash Flow | ||||||
| Free Cash Flow | -254.40M | -269.50M | -168.16M | -153.27M | -377.75M | 385.02M |
| Operating Cash Flow | -225.48M | -211.48M | -39.76M | -49.43M | -260.76M | 449.96M |
| Investing Cash Flow | 397.52M | 515.79M | 201.03M | 284.94M | 329.59M | -305.47M |
| Financing Cash Flow | -135.11M | -175.56M | -180.81M | -219.11M | -124.26M | -51.77M |
TTK Healthcare Limited Technical Analysis
Positive
1082.70
Price Trends
1060.18
Positive
979.72
Positive
962.88
Positive
Market Momentum
21.72
Positive
51.58
Neutral
34.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TTKHLTCARE, the sentiment is Positive. The current price of 1082.7 is below the 20-day moving average (MA) of 1119.74, above the 50-day MA of 1060.18, and above the 200-day MA of 962.88, indicating a neutral trend. The MACD of 21.72 indicates Positive momentum. The RSI at 51.58 is Neutral, neither overbought nor oversold. The STOCH value of 34.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:TTKHLTCARE.
TTK Healthcare Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ₹543.69B | 33.62 | ― | 2.05% | 6.29% | 11.18% | |
79 Outperform | ₹1.10T | 32.73 | ― | 2.12% | 1.85% | -37.51% | |
77 Outperform | ₹480.64B | 44.86 | ― | 2.01% | 5.75% | 12.41% | |
71 Outperform | ₹70.93B | 21.90 | ― | 4.00% | -8.88% | -10.68% | |
66 Neutral | ₹15.77B | 21.31 | ― | 0.89% | 8.34% | 17.25% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:TTKHLTCARE
TTK Healthcare Limited
1,116.05
-42.00
-3.63%
IN:ABBOTINDIA
Abbott India Limited
25,586.10
-4,633.55
-15.33%
IN:CIPLA
Cipla Ltd
1,365.00
-168.50
-10.99%
IN:GLAXO
GlaxoSmithKline Pharmaceuticals Limited
2,837.20
150.40
5.60%
IN:SANOFI
Sanofi India Limited
3,079.85
-1,812.36
-37.05%
IN:SANOFICONR
Sanofi Consumer Healthcare India Limited
4,039.05
-1,166.53
-22.41%
TTK Healthcare Limited Corporate Events
TTK Healthcare Files SEBI Compliance Certificate for June Quarter
Jul 3, 2026
TTK Healthcare Limited has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026. The certificate, issued by its registrar and share transfer age...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.